Virologic effect and hepatotoxicity of BCR::ABL1 tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: A prospective study

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number107597
JournalLeukemia Research
Volume147
DOIs
StatePublished - Dec 2024

Keywords

  • Chronic myeloid leukemia
  • Dasatinib
  • HCV
  • Imatinib
  • Ponatinib
  • Viral hepatitis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this